A detailed history of Bryce Point Capital, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 5,429 shares of ILMN stock, worth $655,117. This represents 0.63% of its overall portfolio holdings.

Number of Shares
5,429
Previous 8,947 39.32%
Holding current value
$655,117
Previous $854 Million 39.6%
% of portfolio
0.63%
Previous 0.72%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$91.69 - $109.88 $322,565 - $386,557
-3,518 Reduced 39.32%
5,429 $516 Million
Q2 2025

Aug 05, 2025

BUY
$70.3 - $95.41 $628,974 - $853,633
8,947 New
8,947 $854 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $19B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Bryce Point Capital, LLC Portfolio

Follow Bryce Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryce Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bryce Point Capital, LLC with notifications on news.